Exeliom Biosciences: a new generation of microbiota-derived biotherapies
… a specific bacterium, Faecalibacterium prausnitzii (Fprau), was consistently absent in patients experiencing a relapse … in the journal PNAS , and now cited more than 4,000 times, established for the first time the immunomodulatory … through the cellular reprogramming of the innate immune system in cancer settings, with the aim of activating it. …
Published on: